甲状腺自身免疫对甲状腺功能正常复发性种植失败患者妊娠结局的影响
该回顾性队列研究纳入2016年11月至2021年9月山东大学附属生殖医院的1031例甲状腺功能正常复发性种植失败患者,按甲状腺自身抗体分为阳性组219例和阴性组812例。调整年龄、BMI、TSH和FT4后,阳性组生化妊娠率显著低于阴性组(OR 1.394,95%CI 1.023-1.901,校正P=0.036),其余妊娠及新生儿结局无显著差异。结论认为甲状腺自身免疫对这类患者IVF/ICSI妊娠结局无影响。
要点
- 甲状腺功能正常复发性种植失败患者中,甲状腺自身免疫阳性组与阴性组的卵巢储备、胚胎质量及妊娠结局无显著差异。
- 调整混杂因素后,阳性组生化妊娠率显著低于阴性组(OR 1.394,95%CI 1.023-1.901,校正P=0.036)。
- 针对甲状腺自身抗体的干预应谨慎实施,需要更多证据。
核心结论
- 甲状腺自身免疫对接受IVF/ICSI的甲状腺功能正常复发性种植失败患者的妊娠结局无影响。
- 临床上针对这类患者甲状腺自身抗体的干预应谨慎实施,需要额外证据。
研究设计与样本
- 回顾性队列研究,2016年11月至2021年9月在山东大学附属生殖医院开展。
- 共纳入1031例甲状腺功能正常的复发性种植失败患者,甲状腺自身免疫阳性组219例,阴性组812例。
主要发现
- 两组卵巢储备、卵巢反应、胚胎质量、妊娠结局及新生儿结局均无显著差异(P > 0.05)。
- 调整年龄、体重指数、促甲状腺激素和游离甲状腺素后,阳性组生化妊娠率显著低于阴性组(OR 1.394,95%CI 1.023-1.901,校正P=0.036)。
- 种植率、临床妊娠率、流产率、死产率及活产率在亚组和分层分析中均无显著差异(P > 0.05)。
临床怎么用
- 作者认为,临床上针对甲状腺功能正常复发性种植失败患者甲状腺自身抗体的干预应谨慎实施,需要额外证据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does thyroid autoimmunity (TAI) adversely affect pregnancy outcomes after IVF/intracytoplasmic sperm injection (ICSI) in euthyroid patients with recurrent implantation failure (RIF)? DESIGN: This retrospective cohort study was conducted at the Reproductive Hospital Affiliated with Shandong University from November 2016 to September 2021. A total of 1031 euthyroid patients diagnosed with RIF were enrolled. Based on serum thyroid autoantibody concentrations, the participants were divided into two groups: the TAI-positive group (219 women with RIF) and the TAI-negative group (812 women with RIF). The parameters were compared between the two groups. Additionally, logistic regression was used to adjust related confounders for primary outcomes, and subgroup and stratified analyses were performed according to different thyroid autoantibody types and TSH concentrations. RESULTS: There was no significant difference in ovarian reserve, ovarian response, embryo quality, pregnancy outcome or neonatal outcome between the two groups (P > 0.05). After adjustments for age, body mass index, thyroid-stimulating hormone and free thyroxine, the biochemical pregnancy rate in the TAI-positive group was significantly lower than that in the TAI-negative group (odds ratio 1.394, 95% CI 1.023-1.901, adjusted P = 0.036). Regarding the implantation rate, clinical pregnancy rate, pregnancy loss rate, stillbirth rate and live birth rate, no significant differences were observed even with subgroup and stratified analyses (P > 0.05). CONCLUSIONS: TAI had no impact on pregnancy outcomes in euthyroid RIF patients who underwent IVF/ICSI. In clinical practice, interventions targeting thyroid autoantibodies in these patients should be implemented with caution and additional evidence is needed.
引用
- Guo L, Wang X, Wang Y, et al. Impact of thyroid autoimmunity on pregnancy outcomes in euthyroid patients with recurrent implantation failure. Reprod Biomed Online. 2023. PMID: 37296069. doi:10.1016/j.rbmo.2023.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。